Introduction
The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line is a valuable tool for studying the function and activity of natural killer (NK) cells. This cell line expresses the human natural cytotoxicity receptor 1 (NCR1), also known as NKp46, which is a key marker for identifying and studying NK cells. In this article, we will explore the structure, activity, and potential applications of this cell line, with a focus on its use as a therapeutic target.
Structure of Human CD335/NCR1/NKp46 HEK293T Stable Cell Line
The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line is derived from the human embryonic kidney cell line HEK293T. This cell line has been stably transfected with the gene encoding for NCR1, resulting in its continuous expression. The HEK293T cell line is a well-established and widely used model system for studying various cellular processes, making it an ideal host for the expression of NCR1.
NCR1 is a type I transmembrane protein that belongs to the natural cytotoxicity receptor family. It is predominantly expressed on the surface of NK cells and plays a crucial role in their function. The receptor consists of two extracellular immunoglobulin-like domains, a transmembrane domain, and a short cytoplasmic tail. The extracellular domains of NCR1 are responsible for binding to ligands on target cells, while the cytoplasmic tail is involved in signaling and activation of NK cells.
Activity of Human CD335/NCR1/NKp46 HEK293T Stable Cell Line
The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line is a valuable tool for studying the activity of NK cells. The stable expression of NCR1 in this cell line allows for the continuous production of the receptor, mimicking the natural state of NK cells. This cell line can be used to study the binding and signaling properties of NCR1, as well as its role in NK cell function.
NK cells are a type of innate immune cell that play a critical role in the body’s defense against viral infections and cancer. NCR1 is one of the key receptors involved in the recognition and elimination of infected or cancerous cells by NK cells. The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line can be used to study the interactions between NCR1 and its ligands on target cells, providing valuable insights into the mechanisms of NK cell activation and cytotoxicity.
Application as a Therapeutic Target
The expression of NCR1 on NK cells makes it a potential therapeutic target for the treatment of various diseases. The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line can be used to screen for compounds or antibodies that can modulate the activity of NCR1. This cell line can also be used to study the effects of these modulators on NK cell function, providing valuable information for the development of novel therapies targeting NCR1.
Furthermore, the stable expression of NCR1 in this cell line allows for the production of a large quantity of the receptor, making it a valuable source for the purification of NCR1 protein. This protein can be used for structural studies and the development of NCR1-targeted therapeutics.
Conclusion
The Human CD335/NCR1/NKp46 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of NCR1. Its stable expression of NCR1 allows for the continuous production of the receptor, making it an ideal model system for studying NK cell function. This cell line has the potential to contribute to the development of novel therapies targeting NCR1 and improving the treatment of diseases such as viral infections and cancer.
There are no reviews yet.